Sofia Westbom-Fremer

418 total citations
12 papers, 299 citations indexed

About

Sofia Westbom-Fremer is a scholar working on Reproductive Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sofia Westbom-Fremer has authored 12 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Sofia Westbom-Fremer's work include Ovarian cancer diagnosis and treatment (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (3 papers). Sofia Westbom-Fremer is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (3 papers). Sofia Westbom-Fremer collaborates with scholars based in Sweden, United States and Denmark. Sofia Westbom-Fremer's co-authors include Patrick Micke, Dijana Djureinovic, Max Backman, Miklós Gulyás, Hans Brunnström, Anna Måsbäck, Ingrid Hedenfalk, Susanne Malander, Päivi Kannisto and Linda Hartman and has published in prestigious journals such as Human Reproduction, The American Journal of Surgical Pathology and Gynecologic Oncology.

In The Last Decade

Sofia Westbom-Fremer

12 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Westbom-Fremer Sweden 7 187 99 68 67 56 12 299
Sotirios Lakis Greece 10 123 0.7× 78 0.8× 30 0.4× 35 0.5× 74 1.3× 21 275
Elena García-Martínez Spain 9 350 1.9× 75 0.8× 223 3.3× 65 1.0× 59 1.1× 19 473
Laura Barker United Kingdom 8 330 1.8× 176 1.8× 48 0.7× 159 2.4× 152 2.7× 17 478
L. Cannella Italy 9 143 0.8× 69 0.7× 31 0.5× 55 0.8× 70 1.3× 26 276
Asaf Maoz United States 9 114 0.6× 32 0.3× 41 0.6× 43 0.6× 72 1.3× 24 269
Benjamin Bonhomme France 8 131 0.7× 81 0.8× 35 0.5× 32 0.5× 45 0.8× 15 261
Qiyu Zhong China 8 72 0.4× 74 0.7× 80 1.2× 24 0.4× 106 1.9× 18 244
Elizabeth Kornaga Canada 11 255 1.4× 68 0.7× 77 1.1× 35 0.5× 152 2.7× 24 437
Shengwei Mo China 11 217 1.2× 50 0.5× 157 2.3× 19 0.3× 93 1.7× 30 348
Carlos Henrique dos Anjos Brazil 10 140 0.7× 103 1.0× 16 0.2× 63 0.9× 48 0.9× 25 280

Countries citing papers authored by Sofia Westbom-Fremer

Since Specialization
Citations

This map shows the geographic impact of Sofia Westbom-Fremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Westbom-Fremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Westbom-Fremer more than expected).

Fields of papers citing papers by Sofia Westbom-Fremer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Westbom-Fremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Westbom-Fremer. The network helps show where Sofia Westbom-Fremer may publish in the future.

Co-authorship network of co-authors of Sofia Westbom-Fremer

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Westbom-Fremer. A scholar is included among the top collaborators of Sofia Westbom-Fremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Westbom-Fremer. Sofia Westbom-Fremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Westbom-Fremer, Sofia, et al.. (2025). Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters. Cancer Immunology Immunotherapy. 74(2). 56–56. 2 indexed citations
2.
Corvigno, Sara, Josefin Fernebro, Sofia Westbom-Fremer, et al.. (2025). High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density. Gynecologic Oncology. 193. 148–155. 3 indexed citations
3.
Linder, Anna, Sofia Westbom-Fremer, Constantina Mateoiu, et al.. (2024). Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma. Human Reproduction. 39(5). 1141–1154. 11 indexed citations
4.
Westbom-Fremer, Sofia, Monica Nistér, Georgia Kokaraki, et al.. (2023). FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology. International Journal of Gynecological Pathology. 43(1). 78–89. 1 indexed citations
5.
Westbom-Fremer, Sofia, Lena Tran, Susanne Malander, et al.. (2021). MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes. 12(5). 742–742. 6 indexed citations
6.
Bennett, Jennifer A., Robert H. Young, Brooke E. Howitt, et al.. (2021). A Distinctive Adnexal (Usually Paratubal) Neoplasm Often Associated With Peutz-Jeghers Syndrome and Characterized by STK11 Alterations (STK11 Adnexal Tumor). The American Journal of Surgical Pathology. 45(8). 1061–1074. 23 indexed citations
7.
Westbom-Fremer, Sofia, et al.. (2020). SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery. Molecular & Cellular Oncology. 7(6). 1805094–1805094. 7 indexed citations
8.
Corvigno, Sara, Artur Mezheyeuski, Sofia Westbom-Fremer, et al.. (2020). High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer. Gynecologic Oncology. 159(3). 860–868. 6 indexed citations
9.
Westbom-Fremer, Sofia, Linda Hartman, Susanne Malander, et al.. (2020). PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(1). 83–91. 45 indexed citations
10.
Bartuma, Katarina, Sofia Westbom-Fremer, Anna Måsbäck, et al.. (2017). Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma. Frontiers in Oncology. 7. 109–109. 20 indexed citations
11.
Brunnström, Hans, Sofia Westbom-Fremer, Max Backman, et al.. (2017). PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability. Modern Pathology. 30(10). 1411–1421. 159 indexed citations
12.
Ghaderi, Mehran, Sofia Westbom-Fremer, Elizabeth Cheek, et al.. (2017). Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas. The American Journal of Surgical Pathology. 41(9). 1231–1237. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026